Blockade of Neuronal α7-nAChR by α-Conotoxin ImI Explained by Computational Scanning and Energy Calculations

α-Conotoxins potently inhibit isoforms of nicotinic acetylcholine receptors (nAChRs), which are essential for neuronal and neuromuscular transmission. They are also used as neurochemical tools to study nAChR physiology and are being evaluated as drug leads to treat various neuronal disorders. A number of experimental studies have been performed to investigate the structure-activity relationships of conotoxin/nAChR complexes. However, the structural determinants of their binding interactions are still ambiguous in the absence of experimental structures of conotoxin-receptor complexes. In this study, the binding modes of α-conotoxin ImI to the α7-nAChR, currently the best-studied system experimentally, were investigated using comparative modeling and molecular dynamics simulations. The structures of more than 30 single point mutants of either the conotoxin or the receptor were modeled and analyzed. The models were used to explain qualitatively the change of affinities measured experimentally, including some nAChR positions located outside the binding site. Mutational energies were calculated using different methods that combine a conformational refinement procedure (minimization with a distance dependent dielectric constant or explicit water, or molecular dynamics using five restraint strategies) and a binding energy function (MM-GB/SA or MM-PB/SA). The protocol using explicit water energy minimization and MM-GB/SA gave the best correlations with experimental binding affinities, with an R2 value of 0.74. The van der Waals and non-polar desolvation components were found to be the main driving force for binding of the conotoxin to the nAChR. The electrostatic component was responsible for the selectivity of the various ImI mutants. Overall, this study provides novel insights into the binding mechanism of α-conotoxins to nAChRs and the methodological developments reported here open avenues for computational scanning studies of a rapidly expanding range of wild-type and chemically modified α-conotoxins.

[1]  D. Yoshikami,et al.  A nicotinic acetylcholine receptor ligand of unique specificity, alpha-conotoxin ImI. , 1994, The Journal of biological chemistry.

[2]  J. Stroud,et al.  Crystal structure of the extracellular domain of nAChR α1 bound to α-bungarotoxin at 1.94 Å resolution , 2007, Nature Neuroscience.

[3]  J Andrew McCammon,et al.  Asymmetric structural motions of the homomeric alpha7 nicotinic receptor ligand binding domain revealed by molecular dynamics simulation. , 2003, Biophysical journal.

[4]  W R Gray,et al.  Peptide neurotoxins from fish-hunting cone snails. , 1985, Science.

[5]  S. Sine,et al.  Structural Elements in α-Conotoxin ImI Essential for Binding to Neuronal α7 Receptors* , 1998, The Journal of Biological Chemistry.

[6]  S. Sine,et al.  Pairwise Interactions between Neuronal α7Acetylcholine Receptors and α-Conotoxin ImI* , 1999, The Journal of Biological Chemistry.

[7]  S. Heinemann,et al.  alpha-Conotoxin ImI exhibits subtype-specific nicotinic acetylcholine receptor blockade: preferential inhibition of homomeric alpha 7 and alpha 9 receptors. , 1995, Molecular pharmacology.

[8]  A. Arseniev,et al.  NMR spatial structure of α‐conotoxin ImI reveals a common scaffold in snail and snake toxins recognizing neuronal nicotinic acetylcholine receptors 1 , 1999, FEBS letters.

[9]  A. Ménez,et al.  Minimal conformation of the ±‐conotoxin ImI for the ±7 neuronal nicotinic acetylcholine receptor recognition: correlated CD, NMR and binding studies , 1999, FEBS letters.

[10]  Berk Hess,et al.  LINCS: A linear constraint solver for molecular simulations , 1997, J. Comput. Chem..

[11]  Vincent B. Chen,et al.  Correspondence e-mail: , 2000 .

[12]  Tingjun Hou,et al.  Assessing the performance of the molecular mechanics/Poisson Boltzmann surface area and molecular mechanics/generalized Born surface area methods. II. The accuracy of ranking poses generated from docking , 2011, J. Comput. Chem..

[13]  G. Bulaj,et al.  Conotoxins and the posttranslational modification of secreted gene products , 2005, Cellular and Molecular Life Sciences CMLS.

[14]  Reena Halai,et al.  Conotoxins: natural product drug leads. , 2009, Natural product reports.

[15]  P. Taylor,et al.  Protein folding determinants: structural features determining alternative disulfide pairing in alpha- and chi/lambda-conotoxins. , 2007, Biochemistry.

[16]  D. Case,et al.  Theory and applications of the generalized born solvation model in macromolecular simulations , 2000, Biopolymers.

[17]  Antoine Taly,et al.  Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system , 2009, Nature Reviews Drug Discovery.

[18]  A. Nicke,et al.  Determination of α‐conotoxin binding modes on neuronal nicotinic acetylcholine receptors , 2004, Journal of molecular recognition : JMR.

[19]  M. L. Connolly.  Solvent-accessible surfaces of proteins and nucleic acids. , 1983, Science.

[20]  J. Thornton,et al.  Stereochemical quality of protein structure coordinates , 1992, Proteins.

[21]  H. Lester,et al.  Long-range coupling in an allosteric receptor revealed by mutant cycle analysis. , 2009, Biophysical journal.

[22]  Edward D Levin,et al.  Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function. , 2007, Biochemical pharmacology.

[23]  J. Changeux,et al.  Functional determinants by which snake and cone snail toxins block the α7 neuronal nicotinic acetylcholine receptors , 1998, Journal of Physiology-Paris.

[24]  D. Craik,et al.  Conopeptide characterization and classifications: an analysis using ConoServer. , 2010, Toxicon : official journal of the International Society on Toxinology.

[25]  Nir London,et al.  The structural basis of peptide-protein binding strategies. , 2010, Structure.

[26]  D. Craik,et al.  Scanning Mutagenesis of α-Conotoxin Vc1.1 Reveals Residues Crucial for Activity at the α9α10 Nicotinic Acetylcholine Receptor* , 2009, The Journal of Biological Chemistry.

[27]  D. Craik,et al.  Solution structure of alpha-conotoxin ImI by 1H nuclear magnetic resonance. , 1999, Journal of medicinal chemistry.

[28]  Xicheng Wang,et al.  Mechanics of Channel Gating of the Nicotinic Acetylcholine Receptor , 2008, PLoS Comput. Biol..

[29]  Paolo Carloni,et al.  A structural model of agonist binding to the α3β4 neuronal nicotinic receptor , 2003 .

[30]  T. Liljefors,et al.  Rational design of alpha-conotoxin analogues targeting alpha7 nicotinic acetylcholine receptors: improved antagonistic activity by incorporation of proline derivatives. , 2009, The Journal of biological chemistry.

[31]  J. Changeux,et al.  Models of the extracellular domain of the nicotinic receptors and of agonist- and Ca2+-binding sites , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[32]  N. Unwin,et al.  Refined structure of the nicotinic acetylcholine receptor at 4A resolution. , 2005, Journal of molecular biology.

[33]  J. McIntosh,et al.  Conus peptides targeted to specific nicotinic acetylcholine receptor subtypes. , 1999, Annual review of biochemistry.

[34]  D. Case,et al.  Exploring protein native states and large‐scale conformational changes with a modified generalized born model , 2004, Proteins.

[35]  Richard A Houghten,et al.  A Synthetic Combinatorial Strategy for Developing α-Conotoxin Analogs as Potent α7 Nicotinic Acetylcholine Receptor Antagonists* , 2009, The Journal of Biological Chemistry.

[36]  K. Wafford,et al.  The Cys-loop superfamily of ligand-gated ion channels: the impact of receptor structure on function. , 2004, Biochemical Society transactions.

[37]  M. Zoli,et al.  Rodent Habenulo–Interpeduncular Pathway Expresses a Large Variety of Uncommon nAChR Subtypes, But Only the α3β4* and α3β3β4* Subtypes Mediate Acetylcholine Release , 2009, The Journal of Neuroscience.

[38]  P. Kollman,et al.  Use of MM-PBSA in reproducing the binding free energies to HIV-1 RT of TIBO derivatives and predicting the binding mode to HIV-1 RT of efavirenz by docking and MM-PBSA. , 2001, Journal of the American Chemical Society.

[39]  P. Taylor,et al.  Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations , 2005, The EMBO journal.

[40]  Molecular modeling of the alpha9alpha10 nicotinic acetylcholine receptor subtype. , 2009, Bioorganic & medicinal chemistry letters.

[41]  Xiaolin Cheng,et al.  Targeted Molecular Dynamics Study of C-Loop Closure and Channel Gating in Nicotinic Receptors , 2006, PLoS Comput. Biol..

[42]  B. Olivera,et al.  Conus venoms: a rich source of novel ion channel-targeted peptides. , 2004, Physiological reviews.

[43]  M. Zoli,et al.  Heterogeneity and complexity of native brain nicotinic receptors. , 2007, Biochemical pharmacology.

[44]  Huanxiang Liu,et al.  Molecular basis of the interaction for an essential subunit PA-PB1 in influenza virus RNA polymerase: insights from molecular dynamics simulation and free energy calculation. , 2010, Molecular pharmaceutics.

[45]  Xun Li,et al.  Interpretation of the Binding Affinities of PTP1B Inhibitors with the MM-GB/SA Method and the X-Score Scoring Function , 2009, J. Chem. Inf. Model..

[46]  M. Romanelli,et al.  Central Nicotinic Receptors: Structure, Function, Ligands, and Therapeutic Potential , 2007, ChemMedChem.

[47]  T. Darden,et al.  Molecular dynamics simulations of biomolecules: long-range electrostatic effects. , 1999, Annual review of biophysics and biomolecular structure.

[48]  S. Arneric,et al.  Neuronal nicotinic receptors: a perspective on two decades of drug discovery research. , 2007, Biochemical pharmacology.

[49]  Carles Pons,et al.  Present and future challenges and limitations in protein–protein docking , 2010, Proteins.

[50]  S. Woodward,et al.  Diversity of Conus neuropeptides. , 1990, Science.

[51]  J. Yakel.  Gating of nicotinic ACh receptors: latest insights into ligand binding and function , 2010, The Journal of physiology.

[52]  Snehasis Chowdhuri,et al.  Dynamical properties of the soft sticky dipole-quadrupole-octupole water model: a molecular dynamics study. , 2006, The Journal of chemical physics.

[53]  Robert C. Edgar,et al.  MUSCLE: a multiple sequence alignment method with reduced time and space complexity , 2004, BMC Bioinformatics.

[54]  T. Blundell,et al.  Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.

[55]  M. Zoli,et al.  Brain nicotinic acetylcholine receptors: native subtypes and their relevance. , 2006, Trends in pharmacological sciences.

[56]  S. Sine,et al.  α-Conotoxins ImI and ImII target distinct regions of the human α7 nicotinic acetylcholine receptor and distinguish human nicotinic receptor subtypes , 2004 .

[57]  Giulio Rastelli,et al.  Fast and accurate predictions of binding free energies using MM‐PBSA and MM‐GBSA , 2009, J. Comput. Chem..

[58]  R. Stevens,et al.  Structure-activity relationships in a peptidic alpha7 nicotinic acetylcholine receptor antagonist. , 2000, Journal of molecular biology.

[59]  David J Craik,et al.  Chemical modification of conotoxins to improve stability and activity. , 2007, ACS chemical biology.

[60]  Harianto Tjong,et al.  Spontaneous conformational change and toxin binding in α7 acetylcholine receptor: Insight into channel activation and inhibition , 2008, Proceedings of the National Academy of Sciences.

[61]  D. Bertrand,et al.  Structural determinants of selective alpha-conotoxin binding to a nicotinic acetylcholine receptor homolog AChBP. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[62]  D. Craik,et al.  alpha-Conotoxins: nicotinic acetylcholine receptor antagonists as pharmacological tools and potential drug leads. , 2001, Current medicinal chemistry.